Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 06/54
John
Cornyn
U.S. Senate · R-TX
Taken from pharma & insurers
$181,375
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 06/54
Pharma & Health$148,471
Insurers & HMOs$32,904
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 6 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$181,375
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Cornyn's control (Alamo PAC and R Senate PAC) took $1,058,000 from banks, card lenders, drug makers and insurers.
Source: FEC; Alamo PAC and R Senate PAC
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
★ Hall of Shame
Cornyn voted with the money in more than one set:
Don't recognize a logo? Here's the key.
Pharma & Health$148,471
Johnson & Johnson$85,563
PhRMA$19,000
Amgen$16,150
Pfizer$8,400
Eli Lilly$8,000
Bristol Myers Squibb$6,050
Merck$5,000
AbbVie$308
Insurers & HMOs$32,904
Anthem/Elevance$15,626
AHIP$9,500
UnitedHealth$4,153
Aetna$2,250
Humana$1,000
Cigna$275
Centene$100